Rapid Response: How Cost Plus Drugs is revolutionizing pharma, with CEO Alex Oshmyansky
Masters of Scale
Revolutionizing Pharmaceuticals
This chapter delves into the advancements and hurdles faced by Cost Plus Drugs as they strive to transform the pharmaceutical industry. It emphasizes the importance of transparency, collaboration with major pharmaceutical companies, and the rapid growth in drug sales, indicating promising developments ahead.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
